• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·PCVX
Held by 2 Gurus
Share

Vaxcyte, Inc. Stocks

$ 73.82Last Updated 05.10.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

$ 8.16B

In Guru Portfolios

Bob Prince, Greg Jensen, Karen Karniol-Tambour

Portfolio Weight (%)

0.0%

Change

+0.01%

Fund

Bridgewater Associates

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Bob Prince, Greg Jensen, Karen Karniol-TambourBridgewater Associates0.0%+0.01%
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.00%

Trending

06.10.2026 15:12

Between Barricades and Investors: Will France Become the New Epicenter of the Eurozone Crisis?

06.10.2026 14:35

Vaxcyte, a vaccine developer, saw its stock price rise by a third in a single day. Is there still room for growth?

06.10.2026 14:13

Burry bought Deckers instead of Lululemon, but wants to buy back his favorite stock in a month

06.10.2026 13:49

Houthis Attacked Saudi Airports and Oil Refineries; Yemen Recaptured a Key Oil Strait

06.10.2026 12:43

Berkshire increased its stake in a major homebuilder. The company's stock fell to a four-year low.

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026